Genopathy
Gene-Disorder Association · Article
Gene
HMGN2P17
High Mobility Group Nucleosomal Binding Domain 2 Pseudogene 17
Disorder
Prostate Cancer
First reported 1950
Supporting publications 1
Key publication · disorder Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases.Journal of the American Medical Association · 1950
Association Review

In brief

The association between HMGN2P17 (High Mobility Group Nucleosomal Binding Domain 2 Pseudogene 17) and Prostate Cancer is reported, supported by a single source.

Sources 1
Clinical variants 0
Symptoms 5
Compounds 0
Trials 0
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
Prostate Cancer

The disorder

20 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
04
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
05
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
06
Provenance

References & sources

6 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access